Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
32.48 USD | +0.03% | 0.00% | +37.51% |
Mar. 22 | Gilead Sciences Completes $4.3 Billion Cymabay Acquisition | MT |
Mar. 22 | CymaBay Therapeutics, Inc.(NasdaqGS:CBAY) dropped from NASDAQ Composite Index | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 157M | Capitalization | 3.73B |
---|---|---|---|---|---|
Net income 2024 * | -129M | Net income 2025 * | -178M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 23.7 x |
P/E ratio 2024 * |
-30.1
x | P/E ratio 2025 * |
-24.2
x | Employees | 101 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.38% |
Latest transcript on CymaBay Therapeutics, Inc.
1 day | +0.03% | ||
1 week | +0.03% | ||
Current month | +0.90% | ||
1 month | +0.50% | ||
3 months | +32.73% | ||
6 months | +115.53% | ||
Current year | +37.51% |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.76% | 4 M€ | -5.15% | - | |
0.05% | 0 M€ | 0.00% | - | |
0.03% | 0 M€ | 0.00% | - | |
0.02% | 735 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-21 | 32.48 | +0.03% | 8,356,254 |
24-03-20 | 32.47 | -0.03% | 1,518,195 |
Delayed Quote Nasdaq, March 21, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+37.51% | 3.73B | |
+2.73% | 108B | |
+9.59% | 104B | |
+6.58% | 23.66B | |
-12.59% | 22.1B | |
-3.29% | 19.71B | |
-35.36% | 18.2B | |
-13.29% | 16.19B | |
+4.68% | 13.72B | |
+34.25% | 12.22B |